Trademark: 79339676
Word
ALENTIS
Status Date
Tuesday, August 15, 2023
Registration Number
7135019
Registration Date
Tuesday, August 15, 2023
Filing Date
Monday, February 7, 2022
Published for Opposition
Tuesday, May 30, 2023
5 Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment
44 Medical analysis services for diagnosing cancer; RNA or DNA analysis for cancer diagnosis and prognosis; provision of medical information in the field of cancer prevention, screening, diagnosis and treatment; medical advice and information regarding pharmaceutical and medical products; medical testing
42 Scientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medicine
The mark consists of the wording ALENTIS with the letter "A" stylized.
Dec 11, 2023
Final Decision Transaction Processed By Ib
Nov 16, 2023
Final Disposition Notice Sent To Ib
Nov 16, 2023
Final Disposition Processed
Nov 15, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 21, 2023
Change Of Name/Address Rec'd From Ib
Aug 15, 2023
Notice Of Registration Confirmation Emailed
Aug 15, 2023
Registered-Principal Register
May 30, 2023
Notification Processed By Ib
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Possible Opposition Sent To Ib
May 10, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 27, 2023
Approved For Pub - Principal Register
Apr 27, 2023
Examiner's Amendment Entered
Apr 27, 2023
Notification Of Examiners Amendment E-Mailed
Apr 27, 2023
Examiners Amendment E-Mailed
Apr 27, 2023
Examiners Amendment -Written
Apr 26, 2023
Teas/Email Correspondence Entered
Apr 26, 2023
Correspondence Received In Law Office
Apr 26, 2023
Teas Response To Office Action Received
Feb 14, 2023
Refusal Processed By Ib
Jan 24, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jan 24, 2023
Refusal Processed By Mpu
Nov 23, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Nov 22, 2022
Non-Final Action Written
Nov 19, 2022
Assigned To Examiner
Nov 10, 2022
Limitation From The Ib Examined And Entered
Jul 16, 2022
Limitation Of Goods Received From Ib
May 10, 2022
Application Filing Receipt Mailed
May 6, 2022
New Application Office Supplied Data Entered
May 5, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
